Breadcrumb

[A05-02] Rapid-acting insulin analogues in the treatment of diabetes mellitus type 1

Overview

Overview

Commission: Commission awarded on 2005-02-22 by the Federal Joint Committee (G-BA)
Status:Commission completed
Department/Division:Drug Assessment
Current document:PDF Executive summary of the final report  [PDF, 134 kB]Further documents
Contact address:to the contact form
Linked projects: [A08-01] Rapid-acting insulin analogues in children and adolescents with diabetes mellitus type 1 - follow-up commission
Status: Commission completed


Report documents

Report documents

PublishedDocumentSizeType 
2007-06-06 Executive summary of the final report 134 kBPDFdownload file
2007-06-06 Final report (German version) 962 kBPDFdownload file
2007-06-06 Documentation and appraisal of comments of comments - Separate appendix to the final report (German version) 26 MBPDFdownload file
2006-09-04 Preliminary report (German version) 626 kBPDFdownload file
2005-08-10 Report plan version 1.0 (German version) 112 kBPDFdownload file


At a glance

Accompanying information

Executive summary of the final report

  File-Icon  Rapid-acting insulin analogues in the treatment of diabetes mellitus type 1 [PDF, 134 kB]

Health information

Further information for consumers and patients is provided on IQWiG's health information website www.informedhealthonline.org.

Type 1 diabetes: Are short-acting insulin analogues better than human insulin?

Press releases

2007-06-06 Rapid-acting insulin analogues in diabetes mellitus type 1: Superiority not proven



Save result list

To save your search result, please copy the link below and paste it into a new tab/window.

close